Early detection and better treatment will reduce the health burden of cardiovascular disease (CVD) and diabetes in New Zealand.
We will develop improved methods of early diagnosis for CVD and prediabetes for individuals. We will also improve existing risk prediction techniques including finding ways to make screening equitable, particularly for Māori and Pacific populations.
By identifying the disparities in CVD risk factor management, particularly with co-morbidities (where people are suffering multiple conditions), we will develop more effective treatments.
Publications
- Living in areas with different levels of earthquake damage and risk of cardiovascular disease: a cohort-linkage study. The Lancet Planetary Health (2017) 1:6 e242–e253
Equitable cardiovascular and diabetes risk prediction: Better cardiovascular and diabetes outcomes in Māori, Pacific, and Indian subcontinent ethnic groups
Science leader and principal investigator:
Co-principal investigator:
Associate investigators:
- Professor Tony Blakely, University of Otago, Wellington
- Professor Rob Doughty, University of Auckland
- Dr Allamanda Faatoese, University of Otago, Christchurch
- Dr Matire Harwood, University of Auckland
- Associate Professor Andrew Kerr, Counties Manukau Health DHB
- Associate Professor Malcolm Legget, University of Auckland
- Associate Professor Rinki Murphy, University of Auckland
- Dr Anna Rolleston, University of Auckland
- Associate Professor Sue Wells, University of Auckland
Related news
- Earthquakes literally broke hearts in New Zealand Reuters Health, September 2017
-
Canterbury quake damage increased risk of cardiovascular disease
- Reaping the benefit of New Zealand’s health data
- Videos from the Diabesity Crisis symposium
- Probiotic may reduce risk of developing diabetes during pregnancy
- Diabetes Xplained: An app for living with type 2 diabetes
- New Deputy Dean for University of Otago Christchurch campus
- Healthier Lives researchers prominent in HRC funding round
- Healthier Lives researchers feature in Gene Genie series
- Using ‘big data’ to assess impacts of health conditions
